Photo from wikipedia
Cystic lymphatic malformations result from an abnormal embryological development of the lymphatic structures. Here we report on a case of a preterm female baby, born at 34 weeks of gestation,… Click to show full abstract
Cystic lymphatic malformations result from an abnormal embryological development of the lymphatic structures. Here we report on a case of a preterm female baby, born at 34 weeks of gestation, with a voluminous cervicofacial cystic lymphatic malformation responsible for an airway obstruction. An mTOR inhibitor, sirolimus, was started from the first day of life, and was combined with iterative sclerotherapy procedures. This case illustrates a safe and successful early administration of sirolimus in a preterm neonate.
Keywords:
lymphatic malformation;
mtor inhibitor;
cystic lymphatic;
sirolimus preterm;
preterm neonate;
inhibitor sirolimus
Journal Title: Frontiers in Pediatrics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Frontiers in Pediatrics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!